Neurology® Podcast

American Academy of Neurology
undefined
Mar 3, 2022 • 20min

Generic Competition for Dimethyl Fumarate

Dr. Jason Crowell talks with 46brooklyn Research CEO Antonio Ciaccia about how Medicare Part D has hidden the benefits of generic competition for Tecfidera, a disease-modifying therapy for multiple sclerosis. Read the full article at 46brooklyn.com.
undefined
Mar 2, 2022 • 38min

March 2022 Neurology Recall: Prognosis and Treatment of Guillain-Barré Syndrome

The March 2022 replay of past episodes showcases a selection of interviews regarding the prognosis and treatment of Guillain-Barré syndrome. This episode features Drs. Ted Burns, Jeff Ratliff, and Michelle Mauermann in conversation with Dr. Bart Jacobs over the course of a decade, highlighting the progress he and his team have made in treating and predicting outcomes in GBS over time.
undefined
Feb 28, 2022 • 14min

Equal Pay for Women Neurologists: Show Us the Money!

Dr. Tesha Monteith talks with Dr. Elizabeth Loder about her editorial on the gender pay gap in academic neurology and its impact on women neurologists as well as the field at large. Read the full article in Neurology.
undefined
Feb 24, 2022 • 13min

Shared Genetics of Migraine, Stroke, and Cervical Dissection

Dr. Andy Southerland talks with Dr. Daniel Chasman about the shared genetic risk of migraine, stroke, and cervical artery dissection (CeAD), a triad of neurologic disorders with vascular involvement. Read the full article in Neurology: Genetics.
undefined
Feb 21, 2022 • 16min

Seizure Frequency in Pregnancy

Dr. Halley Alexander discusses whether epilepsy type, seizure location, or antiseizure medications influence seizure frequency during pregnancy and postpartum with Dr. P. Emanuela Voinescu. Read the full article in Neurology.
undefined
Feb 17, 2022 • 16min

GFAP Autoimmune Syndrome

Dr. Stacey Clardy discusses the clinical, biological, and imaging features—as well as the overall clinical course—of a French cohort of patients with glial fibrillar acidic protein (GFAP) autoantibodies with Dr. Jérôme Honnorat. Read the full article in Neurology.
undefined
Feb 14, 2022 • 20min

Pharmacy Benefits and Disease-Modifying Therapies

Dr. Justin Abbatemarco talks with Dr. Daniel Hartung about the impact of Medicare Part D plan disease-modifying therapy restrictiveness upon adherence and outcomes among patients with multiple sclerosis. Read the full article in Neurology: Clinical Practice.
undefined
Feb 10, 2022 • 16min

Predicting Outcomes in GBS

Dr. Jeff Ratliff talks with Dr. Bart Jacobs about his study on the validity and region-specificity of the modified Erasmus GBS Outcome Score in predicting the risk of walking inability in patients with Guillain-Barré syndrome. Read the full article in Neurology.
undefined
Feb 7, 2022 • 25min

A Neurologist's Personal Experience with DLB

Dr. Stacey Clardy interviews behavioral neurologist Dr. Daniel Drubach about his experience with being diagnosed with Lewy body dementia, highlighting the unique perspective his diagnosis has provided him as a physician and as a patient. Read Dr. Drubach's special article in Continuum: "Twilight and Me: A Soliloquy."
undefined
Feb 3, 2022 • 16min

Practice Guidelines for Painful Diabetic Neuropathy

Dr. Gordon Smith discusses the AAN Guideline Subcommittee's updated Practice Guideline for the oral and topical treatment of painful diabetic neuropathy with Drs. Raymond Price and Brian Callaghan.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app